Clinical trial BYON4228.002
A dose escalation and expansion trial with the SIRP?-directed monoclonal antibody BYON4228 alone and in combination to evaluate the safety, pharmacokinetics, pharmacodynamics and efficacy in patients with advanced or metastatic solid tumors
| Organ | Multiple |
|---|---|
| Trial status | Trial open for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1 |
| Academic trial | Non |
| Sponsor | Byondis |
| EudraCT Identifier | 2024-517952-37-00 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT05737628 |
| Last update |